Marshall Wace’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.7M | Sell |
1,405,250
-783,172
| -36% | -$11M | 0.02% | 534 |
|
2025
Q1 | $29.8M | Buy |
2,188,422
+399,685
| +22% | +$5.44M | 0.04% | 374 |
|
2024
Q4 | $36.5M | Sell |
1,788,737
-178,404
| -9% | -$3.64M | 0.04% | 335 |
|
2024
Q3 | $57.3M | Sell |
1,967,141
-451,692
| -19% | -$13.2M | 0.07% | 228 |
|
2024
Q2 | $56.2M | Buy |
2,418,833
+272,454
| +13% | +$6.33M | 0.08% | 227 |
|
2024
Q1 | $44M | Buy |
2,146,379
+478,982
| +29% | +$9.83M | 0.07% | 254 |
|
2023
Q4 | $35.8M | Buy |
+1,667,397
| New | +$35.8M | 0.06% | 272 |
|
2023
Q2 | – | Sell |
-350,539
| Closed | -$8.08M | – | 2110 |
|
2023
Q1 | $8.08M | Sell |
350,539
-610,100
| -64% | -$14.1M | 0.02% | 677 |
|
2022
Q4 | $26.7M | Buy |
960,639
+284,769
| +42% | +$7.92M | 0.06% | 317 |
|
2022
Q3 | $20.7M | Sell |
675,870
-141,780
| -17% | -$4.35M | 0.05% | 402 |
|
2022
Q2 | $24.1M | Buy |
817,650
+664,795
| +435% | +$19.6M | 0.05% | 351 |
|
2022
Q1 | $4.92M | Sell |
152,855
-231,089
| -60% | -$7.44M | 0.01% | 1231 |
|
2021
Q4 | $17.1M | Sell |
383,944
-147,414
| -28% | -$6.57M | 0.03% | 508 |
|
2021
Q3 | $26.8M | Sell |
531,358
-114,641
| -18% | -$5.78M | 0.11% | 163 |
|
2021
Q2 | $50.7M | Buy |
645,999
+546,481
| +549% | +$42.9M | 0.23% | 64 |
|
2021
Q1 | $5.68M | Buy |
+99,518
| New | +$5.68M | 0.03% | 694 |
|
2020
Q4 | – | Sell |
-325,168
| Closed | -$11.7M | – | 1796 |
|
2020
Q3 | $11.7M | Buy |
325,168
+286,598
| +743% | +$10.3M | 0.07% | 233 |
|
2020
Q2 | $933K | Sell |
38,570
-203,550
| -84% | -$4.92M | 0.01% | 988 |
|
2020
Q1 | $4.24M | Buy |
242,120
+195,743
| +422% | +$3.43M | 0.04% | 420 |
|
2019
Q4 | $808K | Buy |
+46,377
| New | +$808K | 0.01% | 992 |
|
2019
Q2 | – | Sell |
-15,473
| Closed | -$359K | – | 1412 |
|
2019
Q1 | $359K | Buy |
+15,473
| New | +$359K | ﹤0.01% | 1218 |
|